DUX4 and facioscapulohumeral muscular dystrophy: We demonstrated that a biomarker based on suppression of PAX7 target genes hallmarks FSHD muscle biopsies, as well as isolated myoblasts, significantly outperforming DUX4 target gene expression (32,33).